Covid-19 Drug Remdesivir to Cost $3,120 for Typical Patient on Private Insurance – WSJ

Gilead Sciences disclosed its pricing plans as it prepares to begin charging for remdesivir in July. The U.S. has been distributing the drug donated by Gilead since it was authorized for emergency use in May.

Source: Covid-19 Drug Remdesivir to Cost $3,120 for Typical Patient on Private Insurance – WSJ


The article was originally published here!

Comments

Popular posts from this blog

Today’s Top Stories: March 27, 2020

Trump Admin Files Court Order to Block the Sale of John Bolton’s Book

Joe Biden picks Kamala Harris as vice president – The Washington Post